Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Dimarchi

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Molecular Metabolism|March 26, 2025
A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humansBrian Finan, Jonathan D Douros, Ronald Goldwater, et al.
Nature Neuroscience|June 8, 2010
Melanocortin signaling in the CNS directly regulates circulating cholesterolDiego Perez-Tilve, Susanna M Hofmann, Joshua Basford, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
Nature Communications|October 1, 2024
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapyMiguel A Sánchez-Garrido, Víctor Serrano-López, Francisco Ruiz-Pino, et al.
Cell|May 18, 2022
Zn-regulated GTPase metalloprotein activator 1 modulates vertebrate zinc homeostasisAndy Weiss, Caitlin C Murdoch, Katherine A Edmonds, et al.
Nature Metabolism|May 13, 2025
Publisher Correction: GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male miceRobert M Gutgesell, Ahmed Khalil, Arkadiusz Liskiewicz, et al.
Nature Metabolism|April 29, 2025
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male miceRobert M Gutgesell, Ahmed Khalil, Arkadiusz Liskiewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Optimized clinical performance of growth hormone with an expanded genetic codeHo Cho, Tom Daniel, Ying Ji Buechler, et al.
Diabetes|January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actionsKirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Nature Metabolism|July 23, 2020
Targeted pharmacological therapy restores β-cell function for diabetes remissionStephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Molecular Metabolism|March 26, 2025
A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humansBrian Finan, Jonathan D Douros, Ronald Goldwater, et al.
Nature Neuroscience|June 8, 2010
Melanocortin signaling in the CNS directly regulates circulating cholesterolDiego Perez-Tilve, Susanna M Hofmann, Joshua Basford, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
Nature Communications|October 1, 2024
Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapyMiguel A Sánchez-Garrido, Víctor Serrano-López, Francisco Ruiz-Pino, et al.
Cell|May 18, 2022
Zn-regulated GTPase metalloprotein activator 1 modulates vertebrate zinc homeostasisAndy Weiss, Caitlin C Murdoch, Katherine A Edmonds, et al.
Nature Metabolism|May 13, 2025
Publisher Correction: GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male miceRobert M Gutgesell, Ahmed Khalil, Arkadiusz Liskiewicz, et al.
Nature Metabolism|April 29, 2025
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male miceRobert M Gutgesell, Ahmed Khalil, Arkadiusz Liskiewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Optimized clinical performance of growth hormone with an expanded genetic codeHo Cho, Tom Daniel, Ying Ji Buechler, et al.
Diabetes|January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actionsKirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Nature Metabolism|July 23, 2020
Targeted pharmacological therapy restores β-cell function for diabetes remissionStephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, et al.
Pageof 13